LANLUMA

LANLUMA V

Manufacturer: Sinclair Lanluma V is an…

ADD TO CART VIEW PRODUCT

-+

$229.00

Key Benefits of Lanluma

Lanluma exerts both mechanical and biological effects, attributable to its controlled particle size, slow degradation kinetics, and biocompatibility. These features allow for gradual and reproducible correction of volume deficiencies and improvement in skin quality. The resulting collagen synthesis leads to visibly smoother, tighter, and more voluminous tissue in treated regions.

• Long-lasting clinical effects, with results maintained up to 24 months post-procedure
• Minimal invasiveness, enabling outpatient administration with local anesthesia
• Rapid preparation, with reconstitution complete in approximately 10 minutes
• Reduced injection resistance, due to minimal clogging compared to alternative PLLA injectables
• Minimal downtime, with most patients resuming routine activities on the same day
• Supports 2–4 treatment sessions, with visible improvement after 6–12 weeks

Clinical Indications for Lanluma

Lanluma is indicated for soft tissue augmentation, contour enhancement, and dermal rejuvenation in multiple anatomical regions. The device is suitable for aesthetic correction of age-related volume loss, as well as reconstruction following lipoatrophy, postpartum body changes, or scarring.

• Facial rejuvenation: Correction of wrinkles, folds, and areas of volume depletion (e.g., malar, temporal, mandibular regions)
• Gluteal contouring: Volume enhancement and reshaping of buttocks, including correction of asymmetry, “hip dips,” and atrophic zones
• Treatment of cellulite and dermal irregularities in the thighs and arms
• Skin tightening and texture improvement in the décolletage, neck, and hands
• Not recommended for use in periorbital, perioral, or V-shaped buttocks

Lanluma Ingredients

Lanluma consists of a sterile, lyophilized powder for reconstitution, based on poly-L-lactic acid, a synthetic, biodegradable polymer derived from the alpha-hydroxy acid family. PLLA is widely recognized for its use in both medical and aesthetic applications, including suture materials and dermal implants.

• Active component: Poly-L-lactic acid (PLLA) microparticles
• Formulation characteristics:
  • Tight granulometric distribution of microparticles
  • Slow biodegradation rate, allowing prolonged stimulation of fibroblast activity
  • Resorbable and immunologically inert, minimizing the risk of hypersensitivity
  • Physicochemical suitability for both deep and superficial subdermal injection

Available presentations:

• Lanluma V: 210 mg PLLA/vial, indicated for small-area corrections (e.g., face, neck)
• Lanluma X: 630 mg PLLA/vial, indicated for large-volume treatments (e.g., buttocks, thighs)

Lanluma Administration Technique

Lanluma is administered via needle or cannula into subdermal tissue. Treatment protocols vary based on anatomical region, patient characteristics, and aesthetic objectives. Prior to injection, the powder must be reconstituted with sterile water to produce a uniform injectable suspension.

• Reconstitution time: ~10 minutes
• Injection depth: Subdermal (superficial or deep, depending on indication)
• Recommended techniques:
  • Linear retrograde for contouring
  • Micro-droplet for skin tightening and fine correction
• Gluteal augmentation protocol:
  • 1–2 vials per side per session
  • 2–4 treatment sessions, spaced several weeks apart
• Facial rejuvenation protocol:
  • 1–3 sessions, depending on area and desired result
  • Avoid use in periorbital or lip regions

Visible results are typically observed after 6–12 weeks, coinciding with onset of collagen synthesis.

Lanluma Storage Conditions

Maintaining appropriate storage conditions ensures product integrity and performance consistency.

• Storage environment: Store at room temperature in original packaging
• Protect from: Moisture, extreme heat, and direct sunlight
• Shelf life: As indicated on outer packaging; maintain sterility until reconstitution
• Sterilization method: Ethylene oxide

Each vial is intended for single-patient, single-use only.

Lanluma Side Effects

Lanluma exhibits a favorable safety profile when used according to recommended administration protocols. Adverse events reported are generally mild and transient, typically resolving without intervention.

Common Adverse Events

• Localized edema
• Transient erythema
• Bruising at the injection site
• Mild pain or tenderness post-injection

Contraindications

• Injection in periorbital or perioral regions
• Patients with hypersensitivity to PLLA or any device component
• V-shaped buttock anatomy, due to risk of unsatisfactory distribution

No serious adverse events were reported in studies cited within the manufacturer’s clinical materials. However, standard precautions should be observed in patients with autoimmune conditions or active dermatological disorders in the treatment area.

FAQs About Lanluma

How does Lanluma differ from hyaluronic acid fillers?
Lanluma does not provide immediate volume via gel deposition. Instead, it induces collagen neogenesis, resulting in delayed but longer-lasting structural improvements.

When do results become visible?
Patients typically observe improvement from 6 weeks, with peak effects at 2–3 months post-treatment.

How long do results last?
Clinical effects can persist for up to 24 months, depending on patient metabolism and anatomical site.

Can Lanluma be combined with other treatments?
Yes. It may be used adjunctively with modalities such as microneedling, radiofrequency, or chemical peels, subject to practitioner discretion.

Is Lanluma safe for all patients?
Lanluma is generally well tolerated but should be avoided in patients with known allergies to PLLA, active infections, or contraindicated anatomical features.

Buy Lanluma Online

Lanluma® is distributed by Sinclair Pharma Ltd., a UK-based medical aesthetics company. The product is available through licensed medical suppliers to certified healthcare professionals. Clinical use requires appropriate training, with resources available through Sinclair’s official training platform.

Order Lanluma® dermal fillers today on Medica Depot!